The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis

BACKGROUND: Recent guidelines have recommended vancomycin trough levels of 15–20 mg/L for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA). However, high trough levels may increase risk of nephrotoxicity and mortality, and high vancomycin trough levels hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Tongsai, Sasima, Koomanachai, Pornpan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041442/
https://www.ncbi.nlm.nih.gov/pubmed/27686168
http://dx.doi.org/10.1186/s13104-016-2252-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041442/
https://www.ncbi.nlm.nih.gov/pubmed/27686168
http://dx.doi.org/10.1186/s13104-016-2252-7

Ejemplares similares